Publication | Closed Access

A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms

Proteinlipid InteractionBiochemistryMedicineDrug-resistance MechanismsBioconjugationLipid MovementPharmacologyDrug Discovery